- Home
- NOM vs LGVN Comparison
NOM vs LGVN Comparison
Compare NOM & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOM
- LGVN
- Stock Information
- Founded
- NOM 1993
- LGVN 2014
- Country
- NOM United States
- LGVN United States
- Employees
- NOM N/A
- LGVN N/A
- Industry
- NOM Investment Managers
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- NOM Finance
- LGVN Health Care
- Exchange
- NOM Nasdaq
- LGVN Nasdaq
- Market Cap
- NOM 25.0M
- LGVN 23.4M
- IPO Year
- NOM N/A
- LGVN 2021
- Fundamental
- Price
- NOM $10.78
- LGVN $1.23
- Analyst Decision
- NOM
- LGVN Strong Buy
- Analyst Count
- NOM 0
- LGVN 3
- Target Price
- NOM N/A
- LGVN $8.67
- AVG Volume (30 Days)
- NOM 6.9K
- LGVN 132.9K
- Earning Date
- NOM 01-01-0001
- LGVN 05-08-2025
- Dividend Yield
- NOM 3.39%
- LGVN N/A
- EPS Growth
- NOM N/A
- LGVN N/A
- EPS
- NOM N/A
- LGVN N/A
- Revenue
- NOM N/A
- LGVN $2,225,000.00
- Revenue This Year
- NOM N/A
- LGVN N/A
- Revenue Next Year
- NOM N/A
- LGVN $24.82
- P/E Ratio
- NOM N/A
- LGVN N/A
- Revenue Growth
- NOM N/A
- LGVN 127.50
- 52 Week Low
- NOM $8.52
- LGVN $0.77
- 52 Week High
- NOM $10.48
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- NOM 56.60
- LGVN 39.93
- Support Level
- NOM $10.40
- LGVN $1.25
- Resistance Level
- NOM $10.89
- LGVN $1.37
- Average True Range (ATR)
- NOM 0.13
- LGVN 0.09
- MACD
- NOM -0.01
- LGVN -0.01
- Stochastic Oscillator
- NOM 80.00
- LGVN 30.00
About NOM Nuveen Missouri Quality Municipal Income Fund
Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in United States. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Missouri state income taxes; its secondary investment objective is the enhancement of portfolio value. The fund invests in municipal securities as well as floating rate securities as well as derivatives such as futures, options and swap contracts to the necessary extent. Nuveen Fund Advisors, LLC acts as an investment adviser of the company.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.